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1 Department of Microbiology, The University of Tennessee, Knoxville, Knoxville, TN, United States, 2 Department
of Biological Sciences, Duquesne University, Pittsburgh, PA, United States, 3 Department of Plant Pathology
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Candida albicans is an opportunistic human fungal pathogen that causes life-
threatening systemic infections, as well as oral mucosal infections. Phospholipids
are crucial for pathogenesis in C. albicans, as disruption of phosphatidylserine
(PS) and phosphatidylethanolamine (PE) biosynthesis within the cytidine diphosphate
diacylglycerol (CDP-DAG) pathway causes avirulence in a mouse model of systemic
infection. The synthesis of PE by this pathway plays a crucial role in virulence,
but it was unknown if downstream conversion of PE to phosphatidylcholine (PC) is
required for pathogenicity. Therefore, the enzymes responsible for methylating PE to
PC, Pem1 and Pem2, were disrupted. The resulting pem11/1 pem21/1 mutant
was not less virulent in mice, but rather hypervirulent. Since the pem11/1 pem21/1
mutant accumulated PE, this led to the hypothesis that increased PE synthesis
increases virulence. To test this, the alternative Kennedy pathway for PE/PC synthesis
was exploited. This pathway makes PE and PC from exogenous ethanolamine and
choline, respectively, using three enzymatic steps. In contrast to Saccharomyces
cerevisiae, C. albicans was found to use one enzyme, Ept1, for the final enzymatic
step (ethanolamine/cholinephosphotransferase) that generates both PE and PC. EPT1
was overexpressed, which resulted in increases in both PE and PC synthesis. Moreover,
the EPT1 overexpression strain is hypervirulent in mice and causes them to succumb
to system infection more rapidly than wild-type. In contrast, disruption of EPT1 causes
loss of PE and PC synthesis by the Kennedy pathway, and decreased kidney fungal
burden during the mouse systemic infection model, indicating a mild loss of virulence. In
addition, the ept11/1mutant exhibits decreased cytotoxicity against oral epithelial cells
in vitro, whereas the EPT1 overexpression strain exhibits increased cytotoxicity. Taken
altogether, our data indicate that mutations that result in increased PE synthesis cause
greater virulence and mutations that decrease PE synthesis attenuate virulence.
Keywords: Candida albicans, CDP-DAG pathway, EPT1, Kennedy pathway, PEM1, PEM2, phosphatidylcholine,
phosphatidylethanolamine
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INTRODUCTION
Candida albicans is a fungus that typically resides as a commensal
in the gastrointestinal tract of up to 70% of healthy individuals,
as well as within the oral mucosa (Bouza and Munoz, 2008).
However, C. albicans can cause vaginal infections as well as
opportunistic oral and systemic infections, which are more
commonly seen in immunocompromised or immunosuppressed
individuals (Kabir et al., 2012). Systemic blood stream infections
(BSIs) are of particular concern as they have mortality rates
of approximately 30–50% (Williams and Lewis, 2011), and
Candida spp. are the fourth most common causes of BSIs in
the United States (Kabir et al., 2012). Treatment of systemic
infections has encountered some limitations as a result of
poor oral availability and high drug toxicity of some drugs
(Letscher-Bru and Herbrecht, 2003; Mukherjee et al., 2005). In
addition, resistance to standard antifungal treatments such as
fluconazole, by Candida spp., is an emerging issue (Sanguinetti
et al., 2015). It is therefore imperative that novel drug targets are
discovered.
Phospholipid biosynthetic pathways are an attractive area
to search for drug targets, as phospholipids are the major
structural lipids that form cellular membranes (de Kroon
et al., 2013). Cells must therefore synthesize them from
precursors acquired from their environment to support growth
during infection. In addition to having a structural role
within the cell, intermediate phospholipid metabolites can act
as second messengers, and may therefore serve important
regulatory functions (Exton, 1994; de Kroon et al., 2013). As
such, they are required for the growth and pathogenesis of
C. albicans.
The most abundant phospholipids in C. albicans are
phosphatidylglycerol (PG), cardiolipin (CL), phosphatidylserine
(PS), phosphatidylethanolamine (PE), phosphatidylcholine (PC),
and phosphatidylinositol (PI) (Singh et al., 2010; Cassilly et al.,
2017). The major biosynthetic pathway for the phospholipids
PS, PE, and PC in C. albicans is known as the cytidine-
diphosphate diacylglycerol (CDP-DAG) pathway (Figure 1)
(Henry et al., 2012). Within this pathway, the common
phospholipid precursor CDP-DAG is condensed with serine
to form PS by the PS synthase Cho1 (Bae-Lee and Carman,
1984; Henry et al., 2012). PS is then decarboxylated by
one of two PS decarboxylases, Psd1 or Psd2, to form PE
(Henry et al., 2012). Based on work from S. cerevisiae,
PE is predicted to be sequentially methylated by the PE
methyltransferases Pem1 and Pem2 to form PC (Henry et al.,
2012).
Previously, our lab has demonstrated that the cho11/1 and
psd11/1 psd21/1 mutants are avirulent in the mouse model
of systemic infection (Chen et al., 2010). Interestingly, these
mutants are avirulent despite having the ability to utilize an
alternative phospholipid biosynthetic pathway known as the
Kennedy pathway. This pathway uses exogenous ethanolamine
or choline to synthesize PE or PC, respectively (Figure 1)
(Gibellini and Smith, 2010). We have recently reported that
the Kennedy pathway alone cannot support virulence because
the cho11/1 and psd11/1 psd21/1 mutants cannot import
FIGURE 1 | Model for yeast phosphatidylserine (PS),
phosphatidylethanolamine (PE), and phosphatidylcholine (PC) biosynthesis.
Proteins involved in CDP-DAG pathway mediated phospholipid biosynthesis
are shown in purple, and those involved in Kennedy pathway mediated
phospholipid biosynthesis are shown in blue. CDP-DAG, cytidine diphosphate
diacylglycerol; MME, monomethyl phosphatidylethanolamine; DME,
dimethyl-phosphatidylethanolamine; Etn, ethanolamine; Cho, choline; P-Etn,
phosphoethanolamine; P-Cho, phosphocholine; CDP-Etn,
cytidinediphosphoethanolamine; CDP-Cho, cytidinediphosphocholine.
sufficient ethanolamine from the host to support PE synthesis
(Davis et al., 2018). Growth of either mutant is restored
in vitro in medium containing >100 µM ethanolamine, which
is higher than the estimated concentration of ∼30 µM within
the host (Houweling et al., 1992; Davis et al., 2018). In
addition, virulence is restored if PE synthesis is supported
by heterologous expression of the Arabidopsis thaliana serine
decarboxylase (AtSDC) (Davis et al., 2018). This enzyme allows
for decarboxylation of cytoplasmic serine to yield ethanolamine,
which can be used to synthesize PE via the Kennedy pathway.
Thus, AtSDC bypasses deficiencies due to importing low levels of
exogenous ethanolamine (Davis et al., 2018). Therefore, the wild-
type fungus requires the CDP-DAG pathway to generate enough
PE to cause disease since it cannot import enough ethanolamine
to compensate for PE loss using the Kennedy pathway. Loss of
PE synthesis should also impact downstream PC synthesis, and
the impact of PC on virulence has been largely unstudied in this
organism. In this study, we sought to determine if the loss of
PC biosynthesis from the CDP-DAG pathway would attenuate
virulence, or if the Kennedy pathway could compensate for this
loss. In addition, we directly determined if Kennedy pathway
mediated production of PE and/or PC is also important for
virulence in C. albicans when the CDP-DAG pathway is still
functional.
MATERIALS AND METHODS
Strains and Growth Media
Candida albicans strains used in this study were derived from
the SC5314 background (Gillum et al., 1984) (Table 1). Standard
medium used for culturingC. albicanswas YPD (1% yeast extract,
2% dextrose, and 2% peptone) and cultures were maintained
aerobically at 30◦C in a shaking incubator at 225 RPM (Styles,
2002). DH5-α Escherichia coli (NEB, C2987I) were used for
plasmid construction (Table 2), and were cultured in LB broth
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TABLE 1 | Strains used in this study.
Strain Parent strain Genotype Source
SC5314 Clinical isolate Prototrophic wild type Gillum et al., 1984
YLC394 SC5314 PEM1/pem11-SAT1 This Study
YLC401 YLC394 PEM1/pem11-FRT This Study
YLC417 YLC401 pem11/pem1::PMET3-PEM1-SAT1 This Study
YLC393 SC5314 PEM2/pem21-SAT1 This Study
YLC400 YLC393 PEM2/pem21-FRT This Study
YLC405 YLC400 pem21/1-SAT1 This Study
YLC406 YLC405 pem21/1-FRT This Study
BTY38 YLC406 PEM1/pem11 pem21/1-SAT1 This Study
BTY66 BTY38 PEM1/pem11 pem21/1-FRT This Study
BTY72 BTY66 pem11/1 pem21/1-SAT1 This Study
BTY77 BTY72 pem11/1 pem21/1-FRT This Study
BTY138 BTY77 pem11/1 pem21/pem21::PEM2-SAT1 This Study
BTY147 BTY138 pem11/1 pem21/pem21::PEM2 FRT This Study
BTY167 BTY147 pem11/1::PEM1 pem21/pem21::PEM2-SAT1 This Study
BTY169 BTY167 pem11/1::PEM1 pem21/pem21::PEM2-FRT This Study
BTY88 SC5314 PENO1::PENO1-EPT1 This Study
BTY97 SC5314 EPT1/ept11-SAT1 This Study
BTY101 BTY97 EPT1/ept11-FRT This Study
BTY104 BTY101 ept11/1-SAT1 This Study
BTY108 BTY104 ept11/1-FRT This Study
BTY130 BTY108 ept11/1 PENO1::PENO1-EPT1-SAT1 This Study
BTY192 BTY108 ept11/1::EPT1-SAT1 This Study
BTY200 BTY192 ept11/1::EPT1-FRT This Study
TABLE 2 | Plasmids used in this study.
Plasmid Description Parent vector
pSFS2A SAT1 flipper cassette; (CATR) Reuss et al., 2004
pYLC390 PEM1 knockout construct; 5′ NCR (KpnI-ApaI) + 3′ NCR (Sac II-I) of PEM1 pSFS2A
pYLC388 PEM2 knockout construct; 5′ NCR (KpnI-ApaI) + 3′ NCR (Sac II-I) of PEM2 pSFS2A
pYLC314 Methionine repressible expression cassette; SAT1-PMET3 (EcoRI-EcoRI); (AMPR) pBluescript SK+
pYLC315 Methionine repressible expression cassette; SAT1-PMET3 (EcoRI-EcoRI); (AMPR) pBluescript SK+
pYLC410 PEM1 repressible expression vector; 5′ NCR of PEM1 (KpnI-ApaI) + SAT1-PMET3 (EcoRI-EcoRI) pYLC315
pYLC414 PEM1 repressible expression vector; 5′ NCR of PEM1 (KpnI-ApaI) + SAT1-PMET3 (EcoRI-EcoRI) + PEM1 ORF (SacII-SacI) pYLC410
pBT33 PEM2 reintegration construct; 5′ NCR and PEM2 ORF (KpnI-ApaI) + 3′ NCR (SacII-SacI) of PEM2 pYLC388
pBT47 PEM1 reintegration construct; 5′ NCR + PEM1 ORF (ApaI-XhoI) pSFS2A
pBT49 PEM1 reintegration construct; 5′ NCR and PEM1 ORF (ApaI-XhoI) + 3′ NCR (Not1-SacI) of PEM1 pBT47
pBT1 Overexpression Vector; PENO1 (BamHI-Not1) pYLC314
pBT11 EPT1 overexpression cassette; PENO1-EPT1 (NotI-SacI) pBT1
pBT16 EPT1 knockout construct; 5′ NCR and EPT1 ORF (KpnI, XhoI) + 3′ NCR (NotI, SacI) of EPT1 (CATR) pSFS2A
pBT51 EPT1 reintegration construct; 5′ NCR + EPT1 ORF (KpnI-XhoI) pSFS2A
pBT53 EPT1 reintegration construct; 5′ NCR + EPT1 ORF (KpnI-XhoI) + 3′ NCR (SacII-SacI) pBT51
(1% tryptone, 1% NaCl, 0.5% yeast extract) in a rotating incubator
at 37◦C (Guthrie and Fink, 2002).
Plasmid Construction
Primers described in this section are shown in Supplementary
Table S1. The PEM1 knockout vector was created using the SAT1
flipper plasmid pSFS2A (CatR) (Reuss et al., 2004). A 589 bp
region of the PEM1 (CHO2/CR_02540W_A/orf19.169) 5′ non-
coding region (NCR) was amplified using the primers JCO197
and JCO198 which introduced KnpI and ApaI sites, respectively.
This fragment was cloned into theKpnI andApaI sites of pSFS2A.
In addition, a 589 bp 3′ NCR of PEM1 was amplified using
JCO199 and JCO200, and was subsequently cloned into the SacII
and SacI sites of pSFS2A to create the pYLC390 PEM1 knockout
vector.
In addition to the PEM1 knockout vector, a PMET3 repressible
PEM1 expression vector was also created. To create this vector
JCO165 and JCO166 were used to amplify an EcoRI-flanked
Frontiers in Microbiology | www.frontiersin.org 3 February 2019 | Volume 10 | Article 86
fmicb-10-00086 February 5, 2019 Time: 17:13 # 4
Tams et al. PE Modulation Impacts C. albicans Virulence
SAT1-PMET3 fragment from pYLC229 (Chen et al., 2008), which
was subsequently cloned into the EcoRI site of a pBluescript SK+
plasmid to yield two isogenic clones: pYLC314 and pYLC315. The
5′ NCR of PEM1 was amplified from genomic C. albicans DNA
with JCO199 and JCO200 as a KpnI-ApaI fragment and cloned
into pYLC315 (KpnI-ApaI) upstream of the SAT1 marked PMET3
promoter yielding pYLC410. To complete the construct, the
PEM1ORF was amplified along with the 3′NCR with JCO215 and
JCO216, and this SacII-SacI fragment was cloned into pYLC410
downstream of the PMET3 promoter (SacII-SacI) to yield the
PEM1 conditional expression vector pYLC414.
The SAT1 flipper vector pSFS2A was used to create a PEM2
knockout vector, pYLC388 (Reuss et al., 2004). A 592 bp 5′ NCR
to PEM2 (OPI3/C3_06570C_A/orf19.7446) was amplified using
JCO192 and JCO193 and cloned in the KpnI and ApaI sites of
pSFS2A. A 587 bp NCR 3′ to the PEM2 ORF was amplified using
JCO194 and JCO195 and cloned into the SacII and SacI sites,
resulting in pYLC388.
pYLC388 was used to create a reintegration construct for
PEM2. The 5′ NCR was released from pYLC388 by restriction
with ApaI and KpnI. A 1,297 bp fragment including the PEM2
ORF (OPI3/C3_06570C_A/orf19.7446) and approximately
500 bp of NCR 5′ to the ORF was amplified with BTO67 and
JCO192. This fragment was subcloned into pYLC388 at the
ApaI-KpnI sites to create pBT33.
The PEM1 reintegration construct was created using
pSFS2A (Reuss et al., 2004). pSFS2A was linearized
using ApaI and XhoI. A 3451 bp fragment including
approximately 500 bp of the 5′ NCR of PEM1, the PEM1
ORF (CHO2/CR_02540W_A/orf19.169), and approximately
300 bp of the 3′ NCR of PEM1 was amplified using BTO52
and BTO53 to introduce ApaI-XhoI sites, and subsequently was
cloned into the linearized vector to create pBT47. pBT47 was
linearized using NotI and SacI. A 622 bp NCR 3′ to the PEM1
ORF (−356 to −978) was amplified using BTO54 and BTO55
to introduce NotI-SacI sites, and subsequently cloned into the
linearized pBT47 vector to create the PEM1 reintegration vector,
pBT49.
For the construction of an overexpression vector, pYLC314
was used. The PMET3 promoter was removed from pYLC314 by
restriction with PstI, which flanks both sides of the insert. The
constitutively active PENO1 promoter,+928 to+1 5′ of the ENO1
ORF (C1_08500C_A/orf19.395), was amplified from wild type
C. albicans genomic DNA using the primers BTO30 and BTO31
to introduce BamHI and NotI sites, and was cloned into the
BamHI and NotI sites of pYLC314 to create pBT1.
To overexpress EPT1, a 1,509 bp fragment including the EPT1
ORF (C7_02690C_A/orf19.3695) and approximately 300 bp of
NCR 3′ to the ORF was amplified from C. albicans genomic DNA
using BTO35 and BTO36, and was cloned into the NotI and SacI
sites of pBT1 to create the EPT1 overexpression vector, pBT11.
To create an EPT1 knockout vector, the 5′ and 3′ NCRs of the
EPT1 ORF (C7_02690C_A/orf19.3695) were cloned into pSFS2A
plasmid flanking the SAT1 flipper construct (Reuss et al., 2004).
First, a 471 bp fragment of the 5′ NCR of the EPT1 ORF was
amplified from C. albicans genomic DNA using BTO44 and
BTO45 and subsequently cloned into the KpnI and XhoI sites of
pSFS2A. In addition, a 494 bp fragment of the 3′ NCR of EPT1
was amplified with BTO46 and BTO47 and cloned into the NotI
and SacI sites to create pBT16.
To create an EPT1 reintegration construct a 2312 bp fragment
including the EPT1 ORF, 903 bp 5′ NCR of the EPT1 ORF, and
200 bp of the 3′ NCR was amplified from genomic C. albicans
DNA using TRO1044 and TRO1045. This PCR product was
cloned into pSFS2A at the KpnI and XhoI sites to create pBT51.
A 596 bp fragment of the 3′ NCR (+202 to +798) was amplified
from genomic DNA using TRO1046 and TRO1047 and cloned
into the SacI and SacII sites of pBT51 to create the finalized EPT1
reintegration construct, pBT53.
Candida albicans Strain Construction
Plasmids were cut at the indicated restriction site(s) and
linearized fragments were purified using the QIAquick PCR
Purification Kit (QIAGEN, 28106) for single restriction digests,
or the QIAquick Gel Extraction Kit (QIAGEN, 28704) if
restriction digests resulted in multiple fragments. All Candida
albicans transformations were performed via electroporation as
described previously (Hasim et al., 2014) and plates containing
200 µg/mL nourseothricin (GoldBio, N-500-1) were used for
selection of C. albicans transformants (Table 1). Following
transformation, mutations were confirmed via PCR using the
indicated primers (Supplementary Table S1).
To create the pem21/1 strain, pYLC388 was linearized
(KpnI, SacI) and transformed into wild type C. albicans
(SC5314). The SAT1 marker was removed by FLP-mediated
recombination from YLC393 using the SAT1 flipper method to
create YLC400 (PEM2/pem21) (Reuss et al., 2004). Linearized
pYLC388 was again used to transform YLC400, which resulted
in the pem21/1-SAT1 strain (YLC405). The SAT1 marker was
removed by recombination from YLC405 to create YLC406
(pem21/1).
YLC406 was transformed with a linearized pYLC390 fragment
(KpnI, SacI) to create the PEM1/pem11-SAT1 pem21/1mutant
BTY38. The SAT1 marker was removed by recombination to
create BTY66 (PEM1/pem11 pem21/1). BTY66 was again
transformed with linearized pYLC390 (KpnI, SacI) to create
a pem11/1-SAT1 pem21/1 mutant (BTY72), and the SAT1
marker was removed by recombination to create BTY77
(pem11/1 pem21/1).
To reintegrate PEM1 and PEM2 into the homozygous double
mutant, pBT33 was linearized (KpnI, SacI) and transformed
into BTY77 to create a pem11/1 pem21/pem21::PEM2-
SAT1 strain, BTY138. The SAT1 marker was removed
by recombination from BTY138, resulting in BTY147
(pem11/1 pem21/pem21::PEM2). BTY147 was transformed
with linearized pBT49 (ApaI, SacI) to create BTY167
(pem11/1::PEM1 pem21/pem21::PEM2-SAT1). The SAT1
marker was removed by recombination from BTY167 to create
the pem11/1::PEM1 pem21/pem21::PEM2 mutant (BTY169).
To create a repressible PEM1 mutant, SC5314 was
transformed with linearized pYLC390 (KpnI-SacI) to yield
a PEM1/pem11-SAT1 strain (YLC394). The SAT1 marker
was removed by recombination from YLC394 to yield a
PEM1/pem11 strain (YLC401). YLC401 was then transformed
Frontiers in Microbiology | www.frontiersin.org 4 February 2019 | Volume 10 | Article 86
fmicb-10-00086 February 5, 2019 Time: 17:13 # 5
Tams et al. PE Modulation Impacts C. albicans Virulence
with the PEM1 conditional expression vector pYLC414 (KpnI) to
yield a pem11/pem11::PMET3-PEM1-SAT1 strain (YLC417).
To overexpress EPT1, SC5314 was transformed using
linearized pBT11 (MscI) to create BTY88 (PENO1::PENO1-EPT1).
To knock out EPT1, pBT16 was linearized (KpnI, SacI) and
transformed into SC5314 resulting in an EPT1/ept11-SAT1 strain
(BTY97). The SAT1 marker was removed by recombination
from BTY97, resulting in BTY101 (EPT1/ept11). BTY101 was
transformed with linearized pBT16 again to create the ept11/1-
SAT1 strain, BTY104. The SAT1 marker was removed by
recombination from BTY104 to create BTY108 (ept11/1), so
that a reintegrant strain could be produced. Two distinct types
of reintegrant were produced: one in which the EPT1 gene was
constitutively expressed, and another in which one allele of EPT1
was reintegrated into the EPT1 locus under its native promoter.
For the first reintegrant, the overexpression cassette pBT11 was
linearized (MscI) and transformed into BTY108, resulting in the
ept11/1 PENO1::PENO1-EPT1 strain (BTY130). To reintegrate
the gene under its native promoter and at the EPT1 locus,
pBT53 was linearized using KpnI and SacI and subsequently
transformed into BTY108 to yield BTY192 (ept11/1::EPT1-
SAT1). The SAT1 marker was then removed by recombination to
yield BTY200 (ept11/1::EPT1).
Growth Curves
To determine choline auxotrophy, strains were cultured
overnight in liquid YNB medium [0.67% yeast nitrogen base
containing ammonium sulfate (BD Difco, 291940), 2% dextrose],
and then diluted to OD600 nm = 0.1 in triplicate in fresh YNB
(Styles, 2002). Growth was measured at OD600 nm every 2 h
for 12 h or at other time points as indicated. To rescue choline
auxotrophy YNB medium was supplemented with choline
chloride (Fisher Scientific, O1972-250), glycerophosphocholine
(Sigma-Aldrich, G5291-10MG), or lysophosphatidylcholine
(Avanti Polar Lipids INC., 845875P).
Lipid Extraction and TLC
Candida albicans strains were cultured overnight in 5 mL
YNB medium supplemented with 0.25 mM L-methionine/L-
cysteine (represses PEM1 in pYLC417), and then diluted to
an OD600 nm = 0.4 in 25 mL of YNB with 0.25 mM
L-methionine/L-cysteine or YNB supplemented with 1 mM
choline chloride and 0.25 mM L-methionine/L-cysteine. Cultures
were maintained at 30◦C for 12 h at 225 RPM and then
transferred to 50 mL conical tubes and pelleted at 3000 RPM
for 10 min. Pellets were lyophilized and weighed to normalize
for the number of cells present. Following lyophilization,
pellets were washed with 25 mL water and resuspended in
3 mL ethanol:water (4:1). Suspensions were heated in boiling
water for 15 min and pelleted at 3,000 RPM for 10 min.
The supernatant was transferred to new tubes and back
extractions were completed twice using 1 mL of ethanol:water
(4:1) following the above procedure. Lipids were dried under
nitrogen gas and resuspended in chloroform:methanol (2:1).
TLC plates were washed once with chloroform:methanol
(2:1) and dried at 100◦C for 15 min. Lipid extracts were
spot inoculated on TLC plates (Millipore, HX377581) and
chloroform:ethanol:water:triethylamine (35:30:7:35) was used as
a solvent system for separation (Chen et al., 2010). Phospholipids
were visualized under UV following treatment with primuline
(Fisher Scientific, 8064-60-6).
Mouse Models
Outbred male ICR mice were obtained from Envigo for use in
this study. C. albicans strains were cultured overnight in 50 mL
YPD at 30◦C and 225 RPM. After approximately 16 h they
were transferred to 50 mL Falcon tubes and centrifuged at 3,500
RPM for 5 min. The pellets were subsequently washed twice
with 25 mL of water. Cells were counted via hemocytometer and
diluted to 5 × 106 cells/mL unless otherwise noted. Mice were
injected via the lateral tail vein with 0.1 mL of the C. albicans
suspension. C. albicans suspensions were plated on YPD and
incubated overnight at 30◦C to determine cell viability. Following
infection, mice were monitored for signs of illness for 21 days and
were sacrificed after succumbing to infection.
For experiments in which fungal burden was measured, mice
were sacrificed 5 days post infection and kidneys were harvested.
Kidneys were placed in 1 mL water within pre-weighed whirl-
pack bags and homogenized. Serial dilutions (10−1, 10−2, and
10−3) were prepared in water, and 1 mL of each dilution was
added to 1.1% Noble agar pours (3.5 mL) at 55◦C and poured
onto YPD plates in duplicate for each dilution set. Plates were
incubated at 30◦C overnight and colony forming unit (CFUs)
were counted after 24 h.
Ethics Statement
All mouse model experiments in this study were performed
under an animal protocol (0016-0714) that was approved by
the University of Tennessee Institutional Animal Care and Use
Committee (IACUC). We followed the ethical guidelines set forth
by the National Institute of Health (NIH) for the ethical treatment
of animals.
In vitro Cytotoxicity Assays
The FaDu oral epithelial cell line was used in this study
(Martinez-Lopez et al., 2006). Cells were routinely cultured
in EBSS medium (Fisher Scientific, SH30024.01) with 10%
fetal bovine serum (Fisher Scientific, BP1600-100) and 1%
penicillin/streptomycin (Invitrogen, 15140-122) at 37◦C and 5%
CO2. Prior to the cell killing assay, 5× 105 cells/mL of FaDu cells
were plated in a 24 well plate. For each C. albicans strain, 1 mL
of FaDu cells was plated in triplicate. C. albicans strains were
cultured overnight in 5 mL YPD, and then washed twice with
sterile water. Cells were resuspended in 10 mL H2O and counted
via hemocytometer. Solutions containing 2.5 × 106 cells/mL
of each strain (MOI = 5) were made in EBSS supplemented
with 2% Human Serum (MP Biomedicals, ICN2930149) and 1%
penicillin/streptomycin.
Wells containing FaDu cells were aspirated and 1 mL of
C. albicans cell suspensions were added to FaDu cells for
co-incubation. In addition, the following control wells were
included in triplicate: C. albicans alone, FaDu cells alone, medium
alone, FaDu cells with lysis solution, and lysis solution with
medium. Plates were centrifuged at 250 × g for 5 min and
Frontiers in Microbiology | www.frontiersin.org 5 February 2019 | Volume 10 | Article 86
fmicb-10-00086 February 5, 2019 Time: 17:13 # 6
Tams et al. PE Modulation Impacts C. albicans Virulence
incubated for 4 h at 37◦C at 5% CO2. Following incubation,
plates were spun at 250 × g for 5 min, and 50 µL of each
supernatant were assayed for LDH release using the CytoTox 96 R©
Non-Radioactive Cytotoxicity Assay (Promega, G1780) using
the manufacturer’s protocol. Cytotoxicity was expressed as a
relative percentage of the average wild type cytotoxicity, and
three biological replicates were performed (each with technical
replicates in triplicate).
PC Synthesis Assay
This procedure was done as previously described for a
phosphatidylserine synthase assay with some changes (Bae-
Lee and Carman, 1984; Cassilly et al., 2017). The optimal
PC synthesis assay mixture contained 50 mM Tris-HCl pH
7.5, 0.1% Triton X-100, 0.5 mM MnCl2 and 0.1 mM DAG
(Avanti Polar Lipids INC.) added as a suspension in 1% Triton
X-100 and 0.5 mg protein in a total volume of 0.1 mL.
The assay was performed by monitoring the incorporation
of 0.5 mM cytidine diphosphocholine (Sigma-Aldrich) spiked
with 10% by volume [14C]-methyl cytidine diphosphocholine
(∼0.2 µCi) into the chloroform-soluble product at 37◦C
for a predetermined amount of time. The reaction was
terminated by the addition of 1 mL chloroform:methanol
(2:1). Following this the reaction was extracted as previously
described. Samples were fully dried in scintillation vials,
2.5 mL scintillation fluid was added to each vial, and they
were measured with a liquid scintillation counter (Tri-Carb
2900TR).
In vivo PE Synthesis Assay
Cultures were grown to logarithmic phase at 30◦C in YNB
in media supplemented with 100 µM choline chloride and
0.2 µCi/mL of [14C]ethanolamine. Phospholipids were isolated
as described in Surlow et al. (2014). Lipid extracts representing
equivalent amounts of optical density units (ODUs) were
spotted onto silica gel TLC plates and plates were developed in
chloroform:ethanol:water:triethylamine (30:35:7:35). A Typhoon
8600 phosphorimager was used for visualization and quantitation
of PC and PE regions of intensity (ROI).
Statistical Analyses and BLAST
Parameters
All statistical analyses were carried out using GraphPad
Prism (version 7.04). For mouse survival curves the log-
rank (Mantel–Cox) test was performed and for all other
analyses unpaired t-tests between the indicated strains were
used to determine statistical significance. For all analyses,
p < 0.05 was used as a cutoff to determine statistical
significance. To align protein sequences from S. cerevisiae
to C. albicans, Basic Local Alignment Search Tool Protein–
Protein (BLASTP) was used (NCBI, CGD). Sequences were
obtained for S. cerevisiae S288C from the Saccharomyces Genome
Database (SGD) and BLASTP was performed via the Candida
Genome Database (CGD). The default settings were used to
query assembly 22 of C. albicans SC5314 for hits. These
settings included allowgaps = yes, gapext = 1, gapopen = 11,
matrix = BLOSUM62.
RESULTS
Disruption of PEM1 and PEM2 Causes
Choline Auxotrophy in C. albicans
To determine if CDP-DAG mediated PC biosynthesis is required
for virulence in C. albicans, methylation of PE to PC was
disrupted by constructing a pem11/1 pem21/1 knockout
mutant using the SAT1 flipper method (Reuss et al., 2004).
The pem11/1 pem21/1 mutant is expected to be a choline
auxotroph because it can only make PC from imported choline
via the Kennedy pathway (Figure 1). Therefore, growth of the
pem11/1 pem21/1 mutant was observed for 48 h in minimal
media (YNB) with or without 100 µM choline supplementation
(Figure 2A). Little growth occurred in minimal medium lacking
choline, indicating that the pem11/1 pem21/1 mutant cannot
synthesize PC efficiently due to disruption of the CDP-DAG
pathway. Residual growth of pem11/1 pem21/1 may be due
to the ability to store PC or choline within the cell. Addition of
100 µM choline or reintegration of the methyltransferase genes
(pem11/1::PEM1 pem21/1::PEM2 strain) restored growth to
wild-type levels, which indicates that exogenous choline can be
used to synthesize PC via the Kennedy pathway. In fact, choline
levels as low as 10 µM also restored growth to nearly wild-type
levels (Figure 2B). Choline is found at ∼11 µM in rodent serum
(Klein et al., 1993).
To further investigate the ability of C. albicans to acquire
choline from other exogenous sources we tested several choline-
containing compounds that are commonly found in human and
rodent tissues/serum, including lysophosphatidylcholine (LPC)
and glycerophosphocholine (GPC), (Croset et al., 2000; Ilcol
et al., 2005) to determine if they could also restore growth.
LPC is as high as 450 µM in rat serum (Suarez-Garcia et al.,
2017) and GPC is as high as 4.5 µM, but GPC can be over
1 mM in homogenized brain tissue and approximately 270 µM/g
protein in homogenized kidney tissue (Bauernschmitt and Kinne,
1993; Klein et al., 1993). The growth of the pem11/1 pem21/1
mutant was restored to the wild type level in minimal media when
supplemented with either 100 µM GPC or LPC, and was restored
to nearly wild-type levels even at 10 µM (Figures 2C,D).
To confirm that the pem11/1 pem21/1 mutant’s lack
of growth in choline-free media correlates with loss of PC
synthesis, total lipids were extracted from cells growing in
minimal medium lacking a source of choline, and analyzed by
thin layer chromatography (TLC) (Supplementary Figure S1).
While wild type C. albicans was able to produce PC regardless
of supplementation, the pem11/1 pem21/1 mutant failed to
produce PC unless supplemented with choline.
Single mutants for both PEM1 and PEM2 were also tested
for PC synthesis. For PEM1, a pem11/PEM1::PMET3-PEM1
conditional knockout was used, and for PEM2 a pem21/1
conventional knockout was made. Both were cultured in YNB
with or without 1 mM choline (Supplementary Figure S1). In
addition, the YNB media included 0.25 mM cysteine/methionine
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FIGURE 2 | The pem11/1 pem21/1 mutant is a choline auxotroph. (A) Wild type, pem11/1 pem21/1, and pem11/1::PEM1 pem21/1::PEM2 strains were
grown overnight in minimal media, diluted to an OD600 nm = 0.1, and then cultured for 48 h in minimal media, with or without 100 µM choline (CHO). Wild type and
pem11/1 pem21/1 were also cultured for 48 h in minimal media, with or without varying concentrations of (B) choline (CHO), (C) glycerophosphocholine (GPC), or
(D) lysophosphatidylcholine (LPC). These assays were performed with three biological replicates.
to shut off expression of PEM1 in the pem11/PEM1::PMET3-
PEM1 strain. The pem11/PEM1::PMET3-PEM1 strain was fully
capable of PC production even in the absence of choline
when methionine/cysteine were present, but the pem21/1
mutant failed to produce PC unless supplemented with choline
and there was an increase in the intermediate product
monomethylethanolamine. This resembles S. cerevisiae, in which
PEM2 has overlapping substrate specificity and can methylate PE
(Preitschopf et al., 1993; Henry et al., 2012). This also indicates
that Pem1 cannot efficiently methylate the intermediate products
monomethylethanolamine or dimethylethanolamine to PC on its
own.
PE From the CDP-DAG Pathway
Accumulates in the pem11/1 pem21/1
Mutant
If PE methylation to PC is blocked, it is expected that PE will
accumulate in the cell and PC from this pathway will decrease.
To test this, [14C]ethanolamine radiolabeling assays of whole cells
were performed using the pem11/1 pem21/1 mutant. This
experiment measures the accumulation of PE that is derived
from the Kennedy pathway. There was an approximate 1.44-fold
increase in radiolabeled PE in pem11/1 pem21/1 mutants as
compared to the wild type (∗∗∗p < 0.001) (Figure 3) and little or
no PC was detected. Thus, blockage of PE methylation results in
the expected depletion of labeled PC and a buildup of labeled PE.
When the methyltransferases are reintegrated into the mutant,
statistically significant decreases in PE radiolabel accumulation
and concurrent increases in PC radiolabel accumulation are
measured relative to the mutant (∗p < 0.05). These data do not
measure the total PE and PC in the cells, as the phospholipid
pools produced by the CDP-DAG pathway for PE or the
Kennedy pathway for PC are unlabeled (Figures 1, 3), but the
data do reveal that blockage of the CDP-DAG pathway at this
point increases PE and decreases PC specifically generated from
imported ethanolamine.
Blockage of PC Synthesis by the PE
Methyltransferase Mutant pem11/1
pem21/1 Results in Hypervirulence
Choline, GPC, and LPC can fully support growth of pem11/1
pem21/1 mutants in vitro (Figure 2). These compounds are
all found in the host, and therefore can be used to make PC
by pathways that are alternatives to the CDP-DAG pathway,
such as the Kennedy pathway (Figure 1). However, it was still
possible that loss of PEM1 and PEM2 would affect virulence, so
the mutants were tested in a mouse model of systemic infection.
Outbred ICR mice were infected with 3 × 105 cells each of
either wild type (n = 35), pem11/1 pem21/1 (n = 25), or
pem11/1::PEM1 pem21/1::PEM2 (n = 10) via the tail vein. The
pem11/1 pem21/1 strain is fully virulent (Figure 4), indicating
that PC biosynthesis by the CDP-DAG pathway is not required
for full virulence, as the Kennedy pathway can synthesize enough
PC in vivo to support virulence using choline obtained from the
host.
Moreover, mice infected with the pem11/1 pem21/1mutant
succumb to infection more rapidly than those infected with
wild type (∗∗p < 0.01) (Figure 4). This was unexpected, and
we hypothesized that the pem11/1 pem21/1 mutant might
be more virulent because the blockage of PC biosynthesis by
the CDP-DAG pathway leads to increased PE, as seen in vitro
(Figure 3). This could be because a block of the CDP-DAG
pathway upregulates an alternative PE synthesis pathway, such as
the Kennedy pathway. Alternatively, there may just be a buildup
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FIGURE 3 | The pem11/1 pem21/1 mutant cannot produce PC via the CDP-DAG pathway. Strains were cultured in the presence of [14C]ethanolamine and
incorporation of the radiolabel into PE and PC was quantified using thin-layer chromatography (TLC) of extracted lipids (∗∗∗p < 0.001, ∗p < 0.05; unpaired t-test
compared to wild-type). This assay was performed with biological replicates in triplicate.
FIGURE 4 | The pem11/1 pem21/1 mutant is hypervirulent. Mice were infected via the lateral tail vein with 3 × 105 wild type (WT), pem11/1 pem21/1, or
pem11/1::PEM1 pem21/1::PEM2 cells. Mice infected with the pem11/1 pem21/1 mutant succumb to infection more rapidly than those infected with wild type
C. albicans [∗∗p < 0.01 compared to wild-type; log-rank (Mantel–Cox) test]. The number of mice representing each strain is shown in parenthesis beside each strain.
of PE as it cannot be methylated. In either case, this may have
a downstream effect on virulence. If so, then overexpression of
the Kennedy pathway (overexpression of PE synthesis enzymes
by an alternative means), should increase virulence in a similar
manner.
In Contrast to S. cerevisiae, in
C. albicans One Enzyme, Ept1, Catalyzes
the Final Step for Both PE and PC
Biosynthesis in the Kennedy Pathway
The Kennedy pathway can use exogenous choline and
ethanolamine from the environment to form PC and PE,
respectively, and it also makes PC from internal stores of
choline that have been released by phospholipase activity
(Dowd et al., 2001; Fernandez-Murray et al., 2009). The current
model for the C. albicans Kennedy pathway is inferred from
that characterized in baker’s yeast (Figure 1). In S. cerevisiae
there are two branches of the Kennedy pathway; the CDP-
ethanolamine and CDP-choline branches (Gibellini and Smith,
2010) (Figure 5A). Each branch catalyzes analogous reactions
to convert ethanolamine or choline into PE or PC, respectively.
To begin synthesis of either PE or PC, ethanolamine or
choline are imported into the cell by the ethanolamine/choline
importer Hnm1 (Nikawa et al., 1986, 1990). These precursors
are then phosphorylated by either ethanolamine (Eki1) or
choline (Cki1) kinase to form phosphoethanolamine (P-
Etn) or phosphocholine (P-Cho), respectively (Gibellini and
Smith, 2010). P-Etn and P-Cho are used to form the high-
energy intermediates CDP-ethanolamine and CDP-choline
by the ethanolamine and choline cytidyltransferases, Ect1
and Pct1, respectively (Gibellini and Smith, 2010). Finally,
diacylglycerol is condensed with CDP-ethanolamine by
Ept1 to form PE, or CDP-choline by Cpt1 to form PC,
with the release of CMP in both cases (Gibellini and Smith,
2010).
The two S. cerevisiae enzymes that represent each step of
the Kennedy pathway (one from each branch, Figure 5A)
share high sequence identity. For example, when searching the
C. albicans protein database in the Candida Genome Database
(CGD) with the Basic Local Alignment Search Tool (BLAST)
using the S. cerevisiae Eki1 sequence as a query, hits are given
for both the C. albicans Eki1 (C7_01320W/orf19.6912) and
Cki1 (C3_05300C/orf19.6966) sequences (e-values of 6e-7 and
8e-87, respectively). The same is true for S. cerevisiae Cki1.
Thus, this holds true for the enzymes in the first two steps
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FIGURE 5 | Candida albicans has a single dual purpose ethanolamine/cholinephosphotransferase. (A) Model for the S. cerevisiae Kennedy pathway and (B)
proposed model for C. albicans Kennedy pathway. Etn, ethanolamine; Cho, choline; P-Etn, phosphoethanolamine; P-Cho, phosphocholine; CDP-Etn,
cytidinediphosphoethanolamine; CDP-Cho, cytidinediphosphocholine.
of the Kennedy pathway. However, we recovered only one
protein sequence when we used BLAST to search CGD with
the S. cerevisiae Ept1 or Cpt1 protein sequences. For either
S. cerevisiae protein, a single C. albicans protein is revealed
that is designated as Ept1 (C7_02690C/orf19.3695), (e-value of
3e-114 for Ept1 and 7e-111 for Cpt1). We hypothesized that
C. albicans differs from S. cerevisiae in that it uses a single
phosphotransferase (C. albicans Ept1) to catalyze the addition of
both CDP-ethanolamine and CDP-choline to DAG to make PE
and PC, respectively (Figure 5B). If so, blocking this step of the
pathway would impede Kennedy pathway mediated synthesis of
both PE and PC. Alternatively, overexpressing it may increase
synthesis of both PE and PC as well.
In order to determine if Ept1 alone catalyzes the final step
of both branches of the Kennedy pathway in C. albicans,
an ept11/1 knockout strain was generated using the SAT1
flipper method (Reuss et al., 2004). In addition, EPT1 was
cloned into an overexpression vector under the control of the
strong, constitutive ENO1 promoter in order to create a PENO1-
EPT1 overexpression plasmid. This PENO1-EPT1 plasmid was
integrated into wild-type C. albicans. In addition, reintegrants
were made for ept11/1 in which one allele of EPT1 was
expressed at its native locus and under control of its native
promoter or the PENO1-EPT1 plasmid was used to reintegrate the
gene.
To determine if these alterations in EPT1 affected PC
synthesis from its precursors CDP-choline and diacylglycerol
(DAG), as predicted, a CDP-cholinephosphotransferase assay was
performed on membranes isolated from each strain. Membranes
were isolated from the strains and incubated with [14C]CDP-
choline and DAG, and the level of [14C]PC synthesized was
measured. Disruption of EPT1 resulted in a total loss of PC
synthesis, while overexpression of EPT1 in wild-type or ept11/1
resulted in twice the level of [14C]PC as found in wild-type
(Figure 6A, ∗∗p < 0.01). Thus, Ept1 is solely responsible for
catalyzing PC synthesis from CDP-choline and DAG.
Due to difficulty in obtaining radiolabeled [14C]CDP-
ethanolamine, the role for C. albicans Ept1 in PE synthesis was
tested by measuring synthesis of [14C]PE from [14C]ethanolamine
in whole cells. Each strain was cultured in minimal (YNB)
media supplemented with [14C]ethanolamine, and lipids
were extracted (Surlow et al., 2014), separated by TLC, and
quantified to measure incorporation of the radiolabel into
PE (Figure 6B, ∗p < 0.05). Confirming our hypothesis, the
ept11/1 strain does not incorporate a detectable amount
of radiolabel into PE. In contrast, the PENO1-EPT1 strain
incorporates increased radiolabel into PE. Finally, the ept11/1
mutant transformed with PENO1-EPT1 or EPT1 on its native
promoter has a restored ability to incorporate the radiolabel
into both phospholipids (Figures 6A,B). Thus, EPT1 solely
catalyzes the final step of both the CDP-choline and CDP-
ethanolamine branches of the Kennedy pathway in C. albicans
(Figure 5B).
Overexpression of EPT1 Results in
Hypervirulence in the Mouse Systemic
Infection Model
Given that overexpression of EPT1 increases PE/PC synthesis
by the Kennedy pathway, we wanted to determine if this would
also cause hypervirulence as observed for pem11/1 pem21/1,
which also accumulates PE (Figure 3). Therefore, wild-type
and PENO1-EPT1 strains were tested in the mouse model of
systemic candidiasis. Mice infected with PENO1-EPT1 C. albicans
succumbed to infection more rapidly than those infected with
wild type (∗∗p < 0.01) (Figure 7A). Thus, the PENO1-EPT1 and
pem11/1 pem21/1 mutants both accumulate PE and exhibit
hypervirulence.
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FIGURE 6 | Biosynthesis of both PC and PE via the Kennedy pathway requires EPT1. (A) Membranes were isolated from all strains and used in an in vitro PC
synthesis assay, where [14C]CDP-choline incorporation into PC was measured. Enzyme activity was measured as counts per minute per milligram of protein, and is
expressed as a percentage of wild-type (∗∗p < 0.01; unpaired t-test compared to wild-type, WT). (B) Each strain was cultured in the presence of [14C]ethanolamine
and incorporation of the radiolabel into PE was quantified by phosphorimager from thin-layer chromatography (∗p < 0.05; compared to wild-type, WT, by the
unpaired t-test). Each of these assays was performed with three biological replicates.
FIGURE 7 | Overexpression of EPT1 causes hypervirulence. (A) Mice infected with PENO1-EPT1 overexpression strain (n = 14) succumb to infection more rapidly
than the wild type (WT, n = 15) [∗∗p < 0.01; compared to WT, log-rank (Mantel–Cox) test]. Mice infected with the isogenic ept11/1 mutant do not differ significantly
from those infected with wild type C. albicans (n = 10). The n-values for wild-type and PENO1-EPT1 were derived from three separate experiments, and those for
ept11/1 were derived from two separate experiments. (B) Mice infected with ept11/1 have a decreased kidney fungal burden 5 days post infection compared to
those infected with the wild type (∗p < 0.05; unpaired t-test, n = 15 mice per strain). Mice infected with the ept11/1 PENO1-EPT1 reintegrant were not significantly
different than those infected with the wild type. Experiments were performed three times using five mice per strain and kidney homogenates were plated with two
technical replicates for reproducibility. (C) Expression level of C. albicans EPT1 affects cytotoxicity in co-culture with human epithelial cells in vitro. The PENO1-EPT1
overexpression strain has increased cytotoxicity (∗p < 0.05; unpaired t-test) compared to wild type, whereas ept11/1 has decreased cytotoxicity (∗∗p < 0.01). The
ept11/1 PENO1-EPT1 reintegrant is not significantly different than wild type for cytotoxicity. Biological replicates were performed in triplicate and technical replicates
were also performed in triplicate (n = 9 total replicates per strain).
We wanted to determine if this hypervirulence would
correlate with increases in kidney fungal burden. Outbred
ICR mice (Envigo) were infected with 5 × 105 cells of the
wild-type and PENO1-EPT1 strains. Five days post infection,
the mice were necropsied and kidneys were harvested to
determine fungal burden. Mice infected with the PENO1-EPT1
overexpression strain exhibited an average increase in fungal
burden of 38.1% when compared to mice infected with wild
type C. albicans, however, this difference was not statistically
significant (Figure 7B, ∗p = 0.1885).
Disruption of EPT1 Results in a Decrease
in Kidney Fungal Burden in Mice
As EPT1 is necessary for PE and PC synthesis through the
Kennedy pathway, and its overexpression increases virulence, we
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tested an ept11/1 mutant in the mouse model to determine if it
exhibits decreased virulence. For survival curves in the systemic
infection model there was not a significant decrease in virulence
for the ept11/1 strain compared to wild type (Figure 7A).
However, it should be noted that mice infected with the ept11/1
strain began to succumb to infection at 11 days post infection,
which is slightly delayed compared to those infected with the
wild-type (which begin to succumb to infection at 7 days post
infection), which may indicate a modest, although not statistically
significant, decrease in virulence. Although there was not a
statistically significant difference in survival curves, mice infected
with the ept11/1 mutant had a significant average decrease in
kidney fungal burden of 44.97% as compared to the wild type
(∗p < 0.05) (Figure 7B). This decrease in fungal burden may
correlate with the slight delay seen in survival curves for mice
infected with the ept11/1 strain. Conversely, mice infected with
the reintegrant ept11/ept11::PENO1-EPT1 strain did not exhibit
any significant differences in fungal burden compared to mice
infected with wild type C. albicans.
EPT1 Expression Affects Cytotoxicity of
C. albicans Against Epithelial Cells
The mechanism by which EPT1 impacts virulence is unclear,
as there are no clear impacts on growth rate in growth curves
(data not shown). Thus, we examined another virulence factor,
which is the ability of C. albicans to damage epithelial cells.
This can be assessed by measuring the release of the cytoplasmic
enzyme lactase dehydrogenase (LDH) from host cells. In order
to measure cytotoxicity of each mutant compared to wild-type,
2.5 × 106 C. albicans cells were co-cultured with human oral
epithelial cells (FaDu cell line). A CytoTox 96 R© cytotoxicity assay
kit (Promega) was used to quantify the release of LDH after 4 h.
There was a statistically significant decrease in cytotoxicity of
the ept11/1 mutant as compared to the wild type (∗∗p < 0.01)
(Figure 7C). Conversely, the PENO1-EPT1 overexpression mutant
has increased cytotoxicity compared to the wild type (∗p < 0.05)
(Figure 7C). The ept11/1 PENO1-EPT1 reintegrant does have a
modest increase in cytotoxicity versus the wild type, but it is not
statistically significant (Figure 7C).
DISCUSSION
In a previous communication we demonstrated that the synthesis
of phospholipids via the CDP-DAG pathway is absolutely
required for Candida albicans to be able to cause disease in
the mouse model of systemic infection (Chen et al., 2010). The
phospholipids produced in this pathway specifically are PS, PE,
and PC (Figure 1). Blocking synthesis of PS or PE by disrupting
the PS synthase (cho11/1 mutant) or both PS decarboxylases
(psd11/1 psd21/1 mutant) results in avirulence (Chen et al.,
2010). Although the full mechanism is not clear (Davis et al.,
2018), PS and PE synthesis by the CDP-DAG pathway clearly play
a crucial role in virulence. However, at the outset of this study the
role of PE’s downstream product, PC, was less clear. In addition,
no prior studies have directly evaluated the role of the Kennedy
pathway with regard to virulence in C. albicans.
Increased PE in Two Different Pathways
Correlates With Hypervirulence
To determine if PC was important for the ability to cause
disease, we blocked CDP-DAG mediated PC biosynthesis by the
pem11/1 pem21/1 mutation. Systemic infections carried out
in mice revealed that this mutation did not block virulence,
but instead mice infected with the pem11/1 pem21/1 mutant
succumb to infection more rapidly than those infected with
wild-type (Figure 4).
The pem11/1 pem21/1 mutation causes a loss of PC
synthesis by methylation of PE, but simultaneously leads to a
build-up of PE (Figure 3). Synthesis of PE has been shown to
be required for virulence (Chen et al., 2010; Davis et al., 2018),
which suggests the possibility that increased PE might lead to
greater virulence. Therefore, we increased PE synthesis through
the Kennedy pathway by overexpressing EPT1 (Figure 6), and
this led to hypervirulence as well (Figure 7A). This suggests that
increased PE synthesis causes hypervirulence, however, it should
be noted that overexpression of EPT1 also causes increased PC
synthesis.
We favor increased synthesis of PE rather than PC as the
explanation for hypervirulence since PE builds up, but PC
goes down in the hypervirulent pem11/1 pem21/1 mutant
(Figure 3). Thus, the common phospholipid to increase in
both pem11/1 pem21/1 and PENO1-EPT1 (Figures 3, 6) is
PE. Furthermore, PE synthesized from either the CDP-DAG or
Kennedy pathways can support virulence (Chen et al., 2010;
Davis et al., 2018). Thus, taken altogether, these data suggest PE
is the primary phospholipid influencing virulence.
However, the mechanism by which elevated PE causes
virulence is not clear at this point. We do note that increased
EPT1 correlates with increased damage of epithelial cells, and
although modest, this assay is measuring only short term
(4 h) damage, so increased damage over time (∼10 days) may
accumulate leading to more rapid terminal infection. However,
the full mechanism by which increased virulence is mediated is
unknown.
EPT1 Is Required for Full Virulence
During Systemic Infections
Overexpression of EPT1 leads to hypervirulence, but we also
wanted to determine whether the Kennedy pathway is required
for full virulence in C. albicans, as this pathway is present in
a variety of eukaryotic pathogens and is required for virulence
in some (Gibellini et al., 2009). Furthermore, it has been
demonstrated that blocking the ability of C. albicans to import
glycerophosphocholine (GPC), an intermediate metabolite that
may be shunted into the Kennedy pathway, attenuates virulence
in the mouse model of systemic infection (Bishop et al., 2013).
Until now, no virulence studies have been performed on the
Kennedy pathway in C. albicans, and so it has also remained
unknown whether this pathway is redundant in C. albicans, or
if it is specifically required for growth in the host.
We found that disruption of EPT1 caused a modest decrease in
kidney fungal burden (Figure 7B), but not a significant increase
in mouse survival (Figure 7A). This modest decrease in fungal
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burden might help explain the modest increase in the time
in which mice begin to succumb to infection in the ept11/1
mutant (11 days) compared to wild-type (7 days) (Figure 7A),
however, the overall difference in curves was not statistically
significant, so the modest decrease in fungal burden does not
appear to have a large impact on overall virulence. The decrease
in kidney fungal burden also correlated with a modest decrease
in damage to epithelial cells (Figure 7C). Thus, it is possible
that the ept11/1 mutant is unable to damage host cells as
well as wild-type C. albicans, and this could help explain the
loss of fungal burden. Also, it is not entirely clear whether
the effect is related to PE or PC, as Ept1 synthesizes both in
C. albicans.
C. albicans Ept1 Synthesizes Both PE
and PC in the Kennedy Pathway
Prior to this study the model for the Kennedy pathway in
C. albicans was based entirely on that elucidated for S. cerevisiae.
However, we found that while all the enzymes involved in the
first two steps of either PE or PC biosynthesis had homologs in
C. albicans, only one enzyme for the last step of synthesis was
found in C. albicans: Ept1. Given the results of the homology
search and the fact that there is some overlap in substrate
specificity between EPT1 and PCT1 in S. cerevisiae (Gibellini
et al., 2009), we hypothesized that this enzyme was responsible for
both PE and PC biosynthesis in C. albicans. This was tested using
[14C] radiolabeling. Our findings are that the knockout cannot
incorporate radiolabeled precursors into either PE or PC, and
that when the gene is overexpressed an increased amount of the
radiolabeled precursors are incorporated into PE and PC. This
indicates that Ept1 is the only enzyme that catalyzes this reaction
in C. albicans, and we can therefore block the Kennedy pathway
by knocking out EPT1 and increase phospholipid synthesis via
this pathway by overexpressing EPT1.
We do not yet fully understand how the Kennedy pathway
influences virulence, but the ability to modulate virulence in
either direction using EPT1 expression levels indicates that this
is an important pathway for controlling the pathogenicity of this
fungus.
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